Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...
Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger ...
(Reuters) - Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing maker's board and former U.S. Food and Drug Administration Commissioner Scott Gottlieb would ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive ...
Illumina (ILMN) stock rises as activist investor Keith Meister joins the board, with Scott Gottlieb named chairman. Read more ...
(Reuters) - Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing maker's board and former U.S. Food and Drug Administration Commissioner Scott Gottlieb would take ...
Scott Gottlieb, MD, has been elected non-executive Chair of Illumina's Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister, founder, Managing Partner ...
Business: Illumina provides sequencing-and array-based solutions for genetic and genomic analysis. It offers products and services to customers in a range of markets, enabling the adoption of ...